Haleon Q1 earnings and consumer confidence impact

What happened: Haleon (NYSE:HLN) reported 2.2% organic revenue growth in Q1, citing pressure on consumer confidence and a weak cold and flu season. Jefferies maintained a 'Buy' rating, arguing for stronger underlying growth once cold and flu volatility is excluded. Haleon appointed Richard Manso as US Chief Marketing Officer to drive consumer agility.

Market impact: The consumer healthcare sector is affected, with Haleon's performance driving investor sentiment. Jefferies' bullish stance suggests potential upside, while consumer confidence weakness may impact demand for over-the-counter products.

What to watch next: Haleon's full-year earnings guidance, due later this year, will provide clarity on the company's outlook. Additionally, upcoming consumer confidence indices will indicate if the weakness is persistent or transitory, further impacting Haleon's performance.